Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus

Endothelium: Journal of Endothelial Cell Research

Volumn 11, Issue 2, 2004, Pages 89-97

  Zou, Ming Hui ^a   Cohen, Richard A ^b   Ullrich, Volker ^c  

^a UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

3 nitrotyrosine; Diabetes; Endothelial dysfunction; Nitric oxide; Peroxynitrite; Prostacyclin

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ADVANCED GLYCATION END PRODUCT; APOLIPOPROTEIN B; C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; INDOMETACIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; NITRATE; NITRIC OXIDE; PEROXYNITRITE; PROSTACYCLIN; PROSTACYCLIN SYNTHASE; PROSTAGLANDIN H2; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; REACTIVE NITROGEN SPECIES; SUPEROXIDE; THIOL; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; THROMBOXANE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1; ZINC ION;

ARTICLE; CARDIOVASCULAR DISEASE; DIABETIC ANGIOPATHY; DRUG ANTAGONISM; DRUG INHIBITION; ENDOTHELIUM LESION; ENZYME ACTIVATION; ENZYME RELEASE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MICROVASCULAR ISCHEMIA; MORBIDITY; MORTALITY; NITRATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; DIABETES MELLITUS; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; HUMANS; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; PEROXYNITROUS ACID; TYROSINE;

EID: 4444236143     PISSN: 10623329     EISSN: None     Source Type: Journal    
DOI: 10.1080/10623320490482619     Document Type: Article

References (56)

1. Griendling K.K., and FitzGerald G.A. (2003) Oxidant stress and cardiovascular injury. Circulation, 108, 1912-1916.
2. Moncada S., and Higgs E.A. (1993) The L-arginine-nitric oxide pathway. New England Journal of Medicine, 329, 2002-2012.
3. Cohen R.A. (1993) Dysfunction of the vascular endothelium in diabetes mellitus. Circulation, V-67-V-76.
4. Crow J.P., and Beckman J.S. (1995) Reactions between nitric oxide, superoxide, and peroxynitrite: Footprints of peroxynitrite in vivo. Advances in Pharmacology, 34, 17-43.
5. Beckman J.S., and Koppenol W.H. (1996) Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. American Journal of Physiology, 271, C1424-C1437.
6. Beckman J.S., Chen J.I., Schiropoulos H., and Crow J.P. (1994) Oxidative chemistry of peroxynitrite. Methods in Enzymology, 233, 229-240.
7. Hui R.E., and Padjama S. (1993) The reaction of NO with superoxide. Free Radical Research Communications, 18, 195-199.
8. Zou M.H., Martin C., and Ullrich V. (1997) Tyrosine nitration as the mechanism of inactivation of prostacyclin synthase by peroxynitrite. Biological Chemistry, 378, 707-713.
9. Zou M.H., Jendral M., and Ullrich V. (1999) Peroxynitrite induces prostaglandin endoperoxide dependent-vasospasm in bovine coronary arteries via nitration of prostacyclin synthase. British Journal of Pharmacology, 126, 1283-1292.
10. Zou M.H., Leist M., and Ullrich V. (1999) Selective nitration of prostacyclin synthase and defective vasorelaxation in atherosclerotic bovine coronary arteries. American Journal of Pathology, 154, 1559-1565.
11. MacMillan-Crow L.A., Crow J.P., Kerby J.D., Beckman J.S., and Thompson A. (1996) Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proceedings of the National Academy of Sciences of the United States of America, 93, 11853-11858.
12. Ischiropoulos H., Duran D., and Horwitz J. (1995) Peroxynitrite-mediated inhibition of DOPA synthesis in PC12 cells. Journal of Neurochemistry, 65, 2366-2372.
13. The Diabetic Control and Complications Trial Research Group. (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine, 329, 977-986.
14. UK Prospective Diabetes Study (UKPDS) Group. (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 352, 837-853.
15. Kannel W.B., and McGee D.L. (1979) Diabetes and cardiovascular disease: The Framingham Study. Journal of the American Medical Association, 241, 2035-2038.
16. Keaney J.F. Jr., Larson M.G., Vasan R.S., Wilson P.W., Lipinska I., Corey D., Massaro J.M., Sutherland P., Vita J.A., Benjamin E.J., and the Framingham Study Investigators. (2003) Obesity and systemic oxidative stress: Clinical correlates of oxidative stress in the Framingham Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 23, 434-439.
17. Ruderman N.B., and Haudenschild C. (1984) Diabetes as an atherogenic factor. Progress in Cardiovascular Diseases, 6, 373-412.
18. Nathan D.M., Lachin J., Cleary P., Orchard T., Brillon D.J., Backlund J.Y., et al.; Diabetes Control and Complications Trial; Epidemiology of Diabetes Interventions and Complications Research Group. (2003) Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. New England Journal of Medicine, 348, 2294-2303.
19. Reaven G.M., Lithell H., and Landsberg L. (1996) Hypertension and associated metabolic abnormalities: The role of insulin resistance and the sympathoafrenal system. New England Journal of Medicine, 334, 374-381.
20. Kelly D.E., Mokan M., Simoneau J.A., and Mandarion L.J. (1993) Interaction between glucose and free fatty acid metabolism in human skeletal muscle. Journal of Clinical Investigation, 92, 91-98.
21. Steinberg H.O., et al. (2000) Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes, 49, 1231-1238.
22. Boden G., Lebed B., Schatz M., Homko C., and Lemieux S. (2001) Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes, 50, 1612-1617.
23. Rosen P., Nawroth P.P., King G., Moller W., Tritschler H.J., and Packer L. (2001) The role of oxidative stress in the onset and progression of diabetes and its complications: A summary of a congress series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes and Metabolism Research Reviews, 17, 189-212.
24. Inoguchi T., et al. (2000) High glucose levels and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NADPH oxidase in cultured vascular cells. Diabetes, 49, 1939-1945.
25. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsomura T., and Kaneda Y. (2000) Normalizing mitochondria superoxide production blocks three pathways of hyperglycemic damage. Nature, 404, 787-790.
26. Aldhahi W., and Hamdy O. (2003) Adipokines, inflammation, and the endothelium in diabetes. Current Diabetes Report, 3, 293-298.
27. Retnakaran R., Hanley A.J., Raif N., Connelly P.W., Sermer M., and Zinman B. (2003) C-reactive protein and gestational diabetes: The central role of maternal obesity. Journal of Clinical Endocrinology and Metabolism, 88, 3507-3512.
28. Tannous M., Rabini R.A., Vignini A., Moretti N., Fumelli P., Zielinski B., Mazzanti L., and Mutus B. (1999) Evidence for iNOS-dependent peroxynitrite production in diabetic platelets. Diabetologia, 42, 539-544.
29. Lyall F., Gibson J.L., Greer I.A., Brockman D.E., Eis A.L.W., and Myatt L. (1998) Increased 3-nitrotyrosine in the diabetic placenta: Evidence for oxidative stress. Diabetes Care, 21, 1753-1758.
30. Ceriello A., Quagliaro L., D'Amico M., Di Filippo C., Marfella R., Nappo F., Berrino L., Rossi F., and Giugliano D. (2002) Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes, 51, 1076-1082.
31. Frustaci A., et al. (2000) Myocardial cell death in human diabetes. Circ. Res., 87, 1123-1132.
32. Zou M.H., Shi C., and Cohen R.A. (2002) High glucose via peroxynitrite causes tyrosine nitration and inactivation of prostacyclin synthase that is associated with TP receptor-mediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells. Diabetes, 51, 198-203.
33. Zou M.H., Yesilkaya A., and Ullrich V. (1999) Peroxynitrite inactivates prostacyclin synthase by heme-thiolate-catalyzed tyrosine nitration. Drug Metabolism Reviews, 31, 343-349.
34. Zou M.H., Daiber A., Peterson J.A., Shoun H., and Ullrich V. (2000) Rapid reactions of heme-thiolate proteins with peroxynitrite as a basis for the inhibition of prostacyclin synthase nitration. Archives in Biochemistry and Biophysics, 376, 149-155.
35. Daiber A., Zou M.H., Bachschmid M., and Ullrich V. (1999) The reaction of ebselen with peroxynitrite: In vitro and in vivo. Biochemical Pharmacology, 59, 153-160.
36. Schmidt P., Youhnovski N., Daiber A., Balan A., Arsic M., Bachschmid M., Przybylski M., Ullrich V. (2003) Specific nitration at tyrosine 430 revealed by high resolution mass spectrometry as basis for redox regulation of bovine prostacyclin synthase. Journal of Biological Chemistry, 278(15), 12813-12819.
37. Zou M.H., and Bachschmid M. (1999) Hypoxia-reoxygenation causes coronary vasospasm via tyrosine nitration of prostacyclin synthase. Journal of Experimental Medicine, 190, 135-139.
38. Hink U., Oelze M., Kolb P., Bachschmid M., Zou M.H., Daiber A., Mollnau H., August M., Baldus S., Tsilimingas N., Walter U., Ullrich V., and Munzel T. (2003) Role for peroxynitrite in the inhibition of prostacyclin synthase in nitrate tolerance. Journal of the American College of Cardiology, 42, 1826-1834.
39. Bachschmid M., Thurau S., Zou M.H., and Ullrich V. (2003) Endothelial cell activation by endotoxin involves superoxide/NO-mediated nitration of prostacyclin synthase and thromboxane receptor stimulation. FASEB Journal, 17, 914-916.
40. Zou M.H., Klein T., Pasquet J.P., and Ullrich V. (1998) Interleukin-1β decreases prostacyclin synthase activity in rat mesangial cells via endogenous peroxynitrite. Biochemical Journal, 336, 507-512.
41. Harrison H.E., Reece A.H., and Johnson M. (1978) Decreased vascular prostacyclin in experimental diabetes. Life Sciences, 23, 351-356.
42. Dollery C.T., Friedman L.A., Hensby C.N., Kohner E., Lewis P.J., Porta M., and Webster J. (1979) Circulating prostacyclin may be reduced in diabetes. Lancet, ii, 1365.
43. Johnson M., Harrison H.E., Raftery A.T., and Elder J.B. (1979) Vascular prostacyclin may be reduced in diabetes in man. Lancet, i, 325-326.
44. Silberbauer K., Schernthaner, and Sinzinger H. (1979) Decreased vascular prostacyclin in juvenile-onset diabetes. New England Journal of Medicine, 300, 366-367.
45. Davis T.M.E., Brown E., Finch D.R., Mitchell M.D., and Turner R.C. (1981) In vitro venous prostacyclin production, plasma 6-keto-PGF1α concentrations, and diabetic retinopathy. British Journal of Medicine, 282, 1259-1262.
46. Karpen C.W., Pritchard K.A. Jr., Merola A.J., and Panganamala R.V. (1982) Alterations of the prostacyclin-thromboxane ratio in streptozotocin induced diabetic rats. Prostaglandins and Leukocyte Medicine, 8, 93-103.
47. Naveh-Floman N., and Moisseiev J. (1982) Prostanoids and thromboxane A2 involvement in diabetic retinopathy. Metabolic, Pediatric, and Systemic Ophthalmology, 6, 321-325.
48. Stuart M.J., Sunderji S.G., and Allen J.B. (1981) Decreased prostacyclin production in the infant of the diabetic mother. Journal of Laboratory and Clinical Medicine, 98, 412-416.
49. Jawerbaum A., Franchi A.M., Gonzalez E.T., Novaro V., and de Gimeno M.A. (1995) Hyperglycemia promotes elevated generation of TXA2 in isolated rat uteri. Prostaglandins, 50, 47-56.
50. Hodgson W.C., King R.G., and Boura A.L. (1990) Augmented potentiation of renal vasoconstrictor responses by thromboxane A2 receptor stimulation in the alloxan-diabetic rat. Journal of Pharmacy and Pharmacology, 42, 423-427.
51. 2. American Journal of Physiology, 257, H13272-H13277.
52. 2 as an endothelium-derived contracting factor in diabetic state. Diabetes, 42, 1246-1252.
53. Dai FX., Diederich A., Skopec J., and Diederich D. (1993) Diabetes-induced endothelial dysfunction in streptozotocin-treated rats: Role of prostaglandin endoperoxides and free radicals. Journal of the American Society of Nephrology, 4, 1327-1336.
54. Zou M.H., Shi S., and Cohen R.A. (2002) Oxidation by peroxynitrite of zinc-thiolate cluster of eNOS uncouples the enzyme in diabetes. Journal of Clinical Investigation, 109, 817-826.
55. Kuzkaya N., Weissmann N., Harrison D.G., and Dikalov S. (2003) Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: Implications for uncoupling endothelial nitric-oxide synthase. Journal of Biological Chemistry, 278, 22546-22554.
56. Landmesser U., Dikalov S., Price S.R., McCann L., Fukai T., Holland S.M., Mitch W.E., and Harrison D.G. (2003) Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. Journal of Clinical Investigation, 111, 1201-1209.